Effects of anti-allergic rhinitis treatment on adherence to nasal positive airway pressure therapy

Effects of anti-allergic rhinitis treatment on adherence to nasal positive airway pressure therapy - allegic rhinitis and nasal positive airway pressure therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010829

Enrollment

200

Registered

2013-05-29

Start date

2010-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea syndrome

Interventions

administration of montelukast or loratadine seasonal or chronic allergic rhinitis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with sleep apnea syndrome treated by CPAP and comorbid allergic rhinitis

Exclusion criteria

Exclusion criteria: patients with nasal polyp or tumor patients with a history of nose surgery within the past 3 years

Design outcomes

Primary

Measure	Time frame
hours of using CPAP per day	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026